Ligand-mediated nanomedicines against breast cancer: a review
- PMID: 35438008
- DOI: 10.2217/nnm-2021-0473
Ligand-mediated nanomedicines against breast cancer: a review
Abstract
Ligand-mediated targeting represents the cutting edge in precision-guided therapy for several diseases. Surface engineering of nanomedicines with ligands exhibiting selective or tailored affinity for overexpressed biomolecules of a specific disease may increase therapeutic efficiency and reduce side effects and recurrence. This review focuses on newly developed approaches and strategies to improve treatment and overcome the mechanisms associated with breast cancer resistance.
Keywords: HER2; TNBC; active targeting; luminal; nanoparticle; receptor-targeted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous